Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: Impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry

Europace

Volumn 12, Issue 8, 2010, Pages 1105-1111

  Pedretti, Roberto F E ^a   Curnis, Antonio ^b   Massa, Riccardo ^c   Morandi, Fabrizio ^d   Tritto, Massimo ^e   Manca, Lorenzo ^f   Occhetta, Eraldo ^g   Molon, Giulio ^h   De Ferrari, Gaetano M ⁱ   Sarzi Braga, Simona ^a   Raciti, Giovanni ^j   Klersy, Catherine ⁱ   Salerno Uriarte, Jorge A ^d  

^a IRCCS   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF INSUBRIA   (Italy)

^e Mater Domini Hospital   (Italy)

^f Department of Cardiology   (Italy)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^h SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

ⁱ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^j Clinical Department Boston Scientific Corporation   (Italy)

more..

Author keywords

Heart failure; Implantable cardioverter defibrillator; Public health expenses

Indexed keywords

ADULT; AGED; ARTICLE; DEFIBRILLATOR; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEART FAILURE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; UNITED STATES;

ADULT; AGED; BUDGETS; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; ITALY; MIDDLE AGED; NEEDS ASSESSMENT; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 77955191207     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq106     Document Type: Article

References (35)

1. Moss AJ, Hall WJ, Cannon DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335:1933-1940
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
6. Bristow MR, Saxon LA, Boehmer J, Crueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
7. Moss AJ. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction, or = 14;30% should receive an implantable cardioverter-defibrillator. Circulation 2005;111:2537-2549
8. Buxton AE. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction, or =30% should receive an implantable cardioverter- defibrillator. Circulation 2005;111:2537-2549
9. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AJ, Hahn RM et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicen-ter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006; 47:2310-2318
10. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Eur Heart J 2007;28:2256-2295
11. Toma M, McAlister FA, Ezekowitz J, Kimber S, Gulamhusein S, Pantano A et al. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria. Am J Cardiol 2006;97:882-885
12. Salerno-Uriarte JA, Pedretti RF, Tritto M, De Ferrari GM, Klersy C, Sallusti L et al. The ALPHA study (T-wave alternans in patients with heart failure): rationale, design and endpoints. Ital Heart J 2004;5:587-592
13. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L et al. Prognostic value of T-wave alternans in patients with heart failure due to nonis-chemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol 2007;50: 1896-1904
14. De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L et al. ALPHA Study Group. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007;9:502-509
15. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K et al. Heart disease and stroke statistics\2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-171.
16. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 2000;5: 167-173
17. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med 2007; 167:490-496
18. Hoes AW, Mosterd A, Grobbee DE. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 1998;19:L2-9.
19. Rengo F, Leosco D, Iacovoni A, Rengo G, Golino L, Borgia F et al. Epidemiology and risk factors for heart failure in the elderly. Ital Heart J 2004;5:9S-16S.
20. Jensen J, Hedin L, Widell C, Agnhom P, Andersson B, Fu M. Characteristics of heart failure in the elderly\a hospital cohort registry-based study. Int J Cardiol 2008;125:191-196
21. Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F et al. IN-CHF Investigators. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002;143:45-55.
22. Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C et al. A Comparison of ICD implantations in the United States versus Italy. Pacing Clin Electrophysiol 2007;30:S143-6.
23. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004. Pacing Clin Electrophysiol 2006;29:S20-8.
24. Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003;7:5-13.
25. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol 2002;13:38-43.
26. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005;46:1536-1540
27. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008;23:13-19
28. Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD et al. Review of the registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhyhtm 2009;5:1359-1363
29. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
30. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008;5:646-653
31. Gradaus R, Block M, Brachmann J, Breithardt G, Huber HG, Jung W et al. German EURID Registry. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results fron the German ICD Registry EURID. Pacing Clin Electrophysiol 2003;26:1511-1518
32. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007;147:251-262
33. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003;41:1510-1518
34. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51: 288-296
35. Hohnloser SH, Ikeda T, Cohen RJ. Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 2009;6:S36-S44.